Rekvina Labs Ltd Financials
Company Logo

Rekvina Labs Ltd Financial Statement

Rekvina Labs Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
RevenueTBA
Operating Expense0.07
Net Profit-0.07
Net Profit MarginTBA
Earning Per Share-0.11
EBIDTA-0.07
Effective Tax RateTBA
Invest in Rekvina Labs Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Rekvina Labs Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue AnnualTBA
Operating Expenses Annual0.02
Operating Profit Annual-0.02
Interest AnnualTBA
DepreciationTBA
Net Profit Annual-0.02
Tax AnnualTBA

Rekvina Labs Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.01
Cash Flow from OperationsTBA
Cash Flow from InvestingTBA
Cash Flow from FinancingTBA
Cash Flow at the End0.01

Rekvina Labs Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)TBA
PBIT Margin (%)TBA
PBT Margin (%)TBA
Net PROFIT Margin (%)TBA
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)TBA
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)TBA

Rekvina Labs Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.15
Total Current Assets Annual0.01
Non Current Assets Annual0.19
Total Shareholders Funds Annual-0.00
Total Assets Annual0.20

Rekvina Labs Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 24, 2024, Rekvina Labs Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.
Yes, Rekvina Labs Ltd is debt-free with a debt-to-equity ratio of 0.00.
In FY 2023 , Rekvina Labs Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.
Rekvina Labs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and NaN% annually, respectively..
Rekvina Labs Ltd's current PE ratio is undefined.
Rekvina Labs Ltd's ROCE averaged -10.8% from the FY ending March 2022 to 2024, with a median of -2.3%. It peaked at 512.5% in March 2024, reflecting strong capital efficiency over the period..
Rekvina Labs Ltd's latest EBIT is Rs. -0.02 Cr, surpassing the average EBIT of Rs. -0.03 Cr over the 5 years..